VU study identifies new gene fusions in melanoma

Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer.

Study to explore new technologies to connect doctors, patients outside medical settings

A five-year study to explore new technologies that automate patient care outside of hospitals and doctors’ offices will identify ways technology can provide real-time feedback and guidance to patients and to alert care coordination teams before health issues escalate.

Children with autism benefit from peer solicitation

Sosman to lead national melanoma research team

Jeffrey Sosman, M.D., professor of Medicine and leader of the Vanderbilt Melanoma Program, will head one of two teams of researchers at prominent national institutions investigating acral melanoma, a skin cancer that typically forms on the hands, soles of the feet or under the fingernails.

Boston surgeon recounts marathon bombing’s lessons

Just before 3 p.m. on April 15, two bombs exploded at the finish line of the Boston Marathon. Of the estimated 27,000 runners and 500,000 spectators present, three people were killed and 281 injured. Preparation, execution and teamwork — along with a large dose of luck — kept casualties to a minimum, according to Mitchel Harris, M.D., chief of the Orthopaedic Trauma Service at Brigham and Women’s Hospital in Boston.

Brady, Rothman set for AACH leadership roles

Donald Brady, M.D., senior associate dean for Graduate Medical Education and Continuing Professional Development, will serve a one-year term as chair of the board of directors of the American Academy on Communication in Healthcare (AACH) for 2014. Brady spent this year serving as president and will transition into a one-year role as chair.